- Advertisement -

Breakthrough study reveals molecular drivers of Alzheimer’s progression

According to the US Centers for Disease Control and Prevention, at least 5.8 million Americans are currently living with Alzheimer's disease, which is the...

Scientists use organoid model to identify potential new pancreatic cancer treatment

A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer treatments, according...

Skin Protein Deficiency Boosts Hypertension via Angiotensin

A groundbreaking study recently published in Nature Communications has unveiled a novel molecular mechanism by which hypertension, a critical global health issue, is exacerbated...

Obesity Reversed in Genome Edited Mice that Produce Their Own GLP-1

Weight-loss and diabetes drugs like GLP-1 receptor agonists have reshaped the treatment landscape, but they come with a catch: frequent injections to maintain their...

Latest Research Report Explores Impact of Covid-19 Outbreak On Biotechnology Reagents...

A proficient data and brilliant forecasting techniques used in this Biotechnology Reagents Market report are synonymous with accurateness and correctness. The document is a...

Research reveals the sex secrets of amphibian singing choruses

Researchers using advanced recording technology have identified how individual songs in amphibian choruses may influence mating, according to a Dartmouth study. Credit: Chris Johnson Researchers using...

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

Biotechnology company SonoThera has raised $125 million in an oversubscribed Series B financing round. The financing was led by Vida Ventures, with participation from...

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

Biotechnology company SonoThera has raised $125 million in an oversubscribed Series B financing round. The financing was led by Vida Ventures, with participation from...

Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins

You know when you are at the eye doctor getting an updated prescription, and suddenly the world snaps into sharper focus? Physicists at the...

more new items

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

Biotechnology company SonoThera has raised $125 million in an oversubscribed Series B financing round. The financing was led by Vida Ventures, with participation from...

Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins

You know when you are at the eye doctor getting an updated prescription, and suddenly the world snaps into sharper focus? Physicists at the...